Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus
Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved..
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 31(2020), 10 vom: 25. Okt., Seite 1320-1335 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Curigliano, G [VerfasserIn] |
---|
Links: |
---|
Themen: |
143011-72-7 |
---|
Anmerkungen: |
Date Completed 21.10.2020 Date Revised 29.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.annonc.2020.07.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313210179 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM313210179 | ||
003 | DE-627 | ||
005 | 20240229233507.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.annonc.2020.07.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1311.xml |
035 | |a (DE-627)NLM313210179 | ||
035 | |a (NLM)32745693 | ||
035 | |a (PII)S0923-7534(20)39948-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Curigliano, G |e verfasserin |4 aut | |
245 | 1 | 0 | |a Managing cancer patients during the COVID-19 pandemic |b an ESMO multidisciplinary expert consensus |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.10.2020 | ||
500 | |a Date Revised 29.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Practice Guideline | |
650 | 7 | |a Granulocyte Colony-Stimulating Factor |2 NLM | |
650 | 7 | |a 143011-72-7 |2 NLM | |
700 | 1 | |a Banerjee, S |e verfasserin |4 aut | |
700 | 1 | |a Cervantes, A |e verfasserin |4 aut | |
700 | 1 | |a Garassino, M C |e verfasserin |4 aut | |
700 | 1 | |a Garrido, P |e verfasserin |4 aut | |
700 | 1 | |a Girard, N |e verfasserin |4 aut | |
700 | 1 | |a Haanen, J |e verfasserin |4 aut | |
700 | 1 | |a Jordan, K |e verfasserin |4 aut | |
700 | 1 | |a Lordick, F |e verfasserin |4 aut | |
700 | 1 | |a Machiels, J P |e verfasserin |4 aut | |
700 | 1 | |a Michielin, O |e verfasserin |4 aut | |
700 | 1 | |a Peters, S |e verfasserin |4 aut | |
700 | 1 | |a Tabernero, J |e verfasserin |4 aut | |
700 | 1 | |a Douillard, J Y |e verfasserin |4 aut | |
700 | 1 | |a Pentheroudakis, G |e verfasserin |4 aut | |
700 | 0 | |a Panel members |e verfasserin |4 aut | |
700 | 1 | |a Addeo, A |e investigator |4 oth | |
700 | 1 | |a Albiges, L |e investigator |4 oth | |
700 | 1 | |a Ascierto, P A |e investigator |4 oth | |
700 | 1 | |a Banerjee, S |e investigator |4 oth | |
700 | 1 | |a Barlesi, F |e investigator |4 oth | |
700 | 1 | |a Caldas, C |e investigator |4 oth | |
700 | 1 | |a Cardoso, F |e investigator |4 oth | |
700 | 1 | |a Cervantes, A |e investigator |4 oth | |
700 | 1 | |a Chaberny, I F |e investigator |4 oth | |
700 | 1 | |a Cherny, N I |e investigator |4 oth | |
700 | 1 | |a Choueiri, T K |e investigator |4 oth | |
700 | 1 | |a Chua, M L K |e investigator |4 oth | |
700 | 1 | |a Criscitiello, C |e investigator |4 oth | |
700 | 1 | |a Curigliano, G |e investigator |4 oth | |
700 | 1 | |a de Azambuja, E |e investigator |4 oth | |
700 | 1 | |a De Ruysscher, D |e investigator |4 oth | |
700 | 1 | |a de Vries, E |e investigator |4 oth | |
700 | 1 | |a Dent, R |e investigator |4 oth | |
700 | 1 | |a Douillard, J Y |e investigator |4 oth | |
700 | 1 | |a D'Ugo, D |e investigator |4 oth | |
700 | 1 | |a Dziadziuszko, R |e investigator |4 oth | |
700 | 1 | |a Faivre-Finn, C |e investigator |4 oth | |
700 | 1 | |a Felip, E |e investigator |4 oth | |
700 | 1 | |a Garassino, M |e investigator |4 oth | |
700 | 1 | |a Garrido, P |e investigator |4 oth | |
700 | 1 | |a Girard, N |e investigator |4 oth | |
700 | 1 | |a Glynne-Jones, R |e investigator |4 oth | |
700 | 1 | |a Golfinopoulos, V |e investigator |4 oth | |
700 | 1 | |a Haanen, J |e investigator |4 oth | |
700 | 1 | |a Hamilton, E |e investigator |4 oth | |
700 | 1 | |a Jänne, P A |e investigator |4 oth | |
700 | 1 | |a Jordan, K |e investigator |4 oth | |
700 | 1 | |a Kanesvaran, R |e investigator |4 oth | |
700 | 1 | |a Kim, S B |e investigator |4 oth | |
700 | 1 | |a Liebert, U G |e investigator |4 oth | |
700 | 1 | |a Lordick, F |e investigator |4 oth | |
700 | 1 | |a Machiels, J P |e investigator |4 oth | |
700 | 1 | |a Michielin, O |e investigator |4 oth | |
700 | 1 | |a Mok, T S K |e investigator |4 oth | |
700 | 1 | |a Morgan, G |e investigator |4 oth | |
700 | 1 | |a Obermannova, R |e investigator |4 oth | |
700 | 1 | |a Park, K |e investigator |4 oth | |
700 | 1 | |a Passaro, A |e investigator |4 oth | |
700 | 1 | |a Pentheroudakis, G |e investigator |4 oth | |
700 | 1 | |a Peters, S |e investigator |4 oth | |
700 | 1 | |a Reck, M |e investigator |4 oth | |
700 | 1 | |a Salazar Soler, R |e investigator |4 oth | |
700 | 1 | |a Scotté, F |e investigator |4 oth | |
700 | 1 | |a Senan, S |e investigator |4 oth | |
700 | 1 | |a Sessa, C |e investigator |4 oth | |
700 | 1 | |a Smyth, E |e investigator |4 oth | |
700 | 1 | |a Soo, R |e investigator |4 oth | |
700 | 1 | |a Soria, J C |e investigator |4 oth | |
700 | 1 | |a Spicer, J |e investigator |4 oth | |
700 | 1 | |a Strasser, F |e investigator |4 oth | |
700 | 1 | |a Tabernero, J |e investigator |4 oth | |
700 | 1 | |a Tan, D S W |e investigator |4 oth | |
700 | 1 | |a Trapani, D |e investigator |4 oth | |
700 | 1 | |a Van Cutsem, E |e investigator |4 oth | |
700 | 1 | |a van Halteren, H |e investigator |4 oth | |
700 | 1 | |a van Schil, P E |e investigator |4 oth | |
700 | 1 | |a Veronesi, G |e investigator |4 oth | |
700 | 1 | |a Yang, J |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 31(2020), 10 vom: 25. Okt., Seite 1320-1335 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2020 |g number:10 |g day:25 |g month:10 |g pages:1320-1335 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2020.07.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2020 |e 10 |b 25 |c 10 |h 1320-1335 |